News
4 hours ago
Cell Therapy
4 hours ago
License out/inImmunotherapyCell Therapy
4 hours ago
AcquisitionLicense out/inADC
4 hours ago
Sanofi secures first FDA approval to treat neurological symptoms in rare metabolic disease
Drug ApprovalBreakthrough TherapyClinical Result
20 Nov 2026
Immuneering Presents Additional Data Demonstrating Atebimetinib’s Broad Potential as a Backbone for Combination Therapy in Pancreatic Cancer
Clinical ResultAACR
20 Nov 2026
Olema Oncology Presents Preclinical Data on Selective KAT6A Degraders in ER+/HER2- Breast Cancer Models at EORTC-NCI-AACR Symposium
Clinical ResultAACR
20 Nov 2026
Telomir Pharmaceuticals Selects Linical to Advance FDA-Cleared Phase 1/2 Clinical Trial of Telomir-Zn in Triple-Negative Breast Cancer
INDClinical StudyLicense out/in
20 Nov 2026
Visara Announces First Patient Dosed in ASCEND Phase 2b Trial of VIS-101 in Wet AMD
Clinical Result
20 Nov 2026
Providence Therapeutics Enrolls First Patient in World’s First Clinical Trial of a Personalized mRNA Vaccine for Pediatric Brain Cancer
VaccinemRNAClinical StudyImmunotherapy